Skip to main content
Top
Published in: Molecular Brain 1/2012

Open Access 01-12-2012 | Research

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

Authors: Yoichi Imaizumi, Yohei Okada, Wado Akamatsu, Masato Koike, Naoko Kuzumaki, Hideki Hayakawa, Tomoko Nihira, Tetsuro Kobayashi, Manabu Ohyama, Shigeto Sato, Masashi Takanashi, Manabu Funayama, Akiyoshi Hirayama, Tomoyoshi Soga, Takako Hishiki, Makoto Suematsu, Takuya Yagi, Daisuke Ito, Arifumi Kosakai, Kozo Hayashi, Masanobu Shouji, Atsushi Nakanishi, Norihiro Suzuki, Yoshikuni Mizuno, Noboru Mizushima, Masayuki Amagai, Yasuo Uchiyama, Hideki Mochizuki, Nobutaka Hattori, Hideyuki Okano

Published in: Molecular Brain | Issue 1/2012

Login to get access

Abstract

Background

Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they do not fully recapitulate the pathophysiology of human PARK2.

Results

Here, we generated induced pluripotent stem cells (iPSCs) from two PARK2 patients. PARK2 iPSC-derived neurons showed increased oxidative stress and enhanced activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. iPSC-derived neurons, but not fibroblasts or iPSCs, exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis. Although PARK2 patients rarely exhibit Lewy body (LB) formation with an accumulation of α-synuclein, α-synuclein accumulation was observed in the postmortem brain of one of the donor patients. This accumulation was also seen in the iPSC-derived neurons in the same patient.

Conclusions

Thus, pathogenic changes in the brain of a PARK2 patient were recapitulated using iPSC technology. These novel findings reveal mechanistic insights into the onset of PARK2 and identify novel targets for drug screening and potential modified therapies for PD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Farrer MJ: Genetics of Parkinson disease: paradigm shifts and future prospects. Nature reviews. 2006, 7: 306-318.CrossRefPubMed Farrer MJ: Genetics of Parkinson disease: paradigm shifts and future prospects. Nature reviews. 2006, 7: 306-318.CrossRefPubMed
2.
go back to reference Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.CrossRefPubMed Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.CrossRefPubMed
3.
go back to reference Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.CrossRefPubMed Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.CrossRefPubMed
4.
go back to reference Whitworth AJ, Pallanck LJ: The PINK1/Parkin pathway: a mitochondrial quality control system?. J Bioenerg Biomembr. 2009, 41: 499-503. 10.1007/s10863-009-9253-3.CrossRefPubMed Whitworth AJ, Pallanck LJ: The PINK1/Parkin pathway: a mitochondrial quality control system?. J Bioenerg Biomembr. 2009, 41: 499-503. 10.1007/s10863-009-9253-3.CrossRefPubMed
5.
go back to reference Youle RJ, Narendra DP: Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011, 12: 9-14. 10.1038/nrm3028.CrossRefPubMed Youle RJ, Narendra DP: Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011, 12: 9-14. 10.1038/nrm3028.CrossRefPubMed
6.
go back to reference Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, et al: Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003, 278: 43628-43635. 10.1074/jbc.M308947200.CrossRefPubMed Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, et al: Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003, 278: 43628-43635. 10.1074/jbc.M308947200.CrossRefPubMed
7.
go back to reference Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J: Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004, 279: 18614-18622. 10.1074/jbc.M401135200.CrossRefPubMed Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J: Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004, 279: 18614-18622. 10.1074/jbc.M401135200.CrossRefPubMed
8.
go back to reference Perez FA, Palmiter RD: Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA. 2005, 102: 2174-2179. 10.1073/pnas.0409598102.PubMedCentralCrossRefPubMed Perez FA, Palmiter RD: Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA. 2005, 102: 2174-2179. 10.1073/pnas.0409598102.PubMedCentralCrossRefPubMed
9.
go back to reference Sato S, Chiba T, Nishiyama S, Kakiuchi T, Tsukada H, Hatano T, Fukuda T, Yasoshima Y, Kai N, Kobayashi K, et al: Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography. J Neurosci Res. 2006, 84: 1350-1357. 10.1002/jnr.21032.CrossRefPubMed Sato S, Chiba T, Nishiyama S, Kakiuchi T, Tsukada H, Hatano T, Fukuda T, Yasoshima Y, Kai N, Kobayashi K, et al: Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography. J Neurosci Res. 2006, 84: 1350-1357. 10.1002/jnr.21032.CrossRefPubMed
10.
go back to reference Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, Feng J: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012, 3: 668-PubMedCentralCrossRefPubMed Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, Feng J: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012, 3: 668-PubMedCentralCrossRefPubMed
11.
go back to reference Mattis VB, Svendsen CN: Induced pluripotent stem cells: a new revolution for clinical neurology?. Lancet Neurol. 2011, 10: 383-394. 10.1016/S1474-4422(11)70022-9.CrossRefPubMed Mattis VB, Svendsen CN: Induced pluripotent stem cells: a new revolution for clinical neurology?. Lancet Neurol. 2011, 10: 383-394. 10.1016/S1474-4422(11)70022-9.CrossRefPubMed
12.
go back to reference Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn-Hardy K, Petrucelli L, Hussey J, et al: Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 2001, 50: 293-300. 10.1002/ana.1132.CrossRefPubMed Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn-Hardy K, Petrucelli L, Hussey J, et al: Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 2001, 50: 293-300. 10.1002/ana.1132.CrossRefPubMed
13.
go back to reference Savitt JM, Dawson VL, Dawson TM: Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006, 116: 1744-1754. 10.1172/JCI29178.PubMedCentralCrossRefPubMed Savitt JM, Dawson VL, Dawson TM: Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006, 116: 1744-1754. 10.1172/JCI29178.PubMedCentralCrossRefPubMed
14.
go back to reference Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y: Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011, 6: e16182-10.1371/journal.pone.0016182.PubMedCentralCrossRefPubMed Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y: Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011, 6: e16182-10.1371/journal.pone.0016182.PubMedCentralCrossRefPubMed
15.
go back to reference Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131: 861-872. 10.1016/j.cell.2007.11.019.CrossRefPubMed Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131: 861-872. 10.1016/j.cell.2007.11.019.CrossRefPubMed
16.
go back to reference Matigian N, Abrahamsen G, Sutharsan R, Cook AL, Vitale AM, Nouwens A, Bellette B, An J, Anderson M, Beckhouse AG, et al: Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech. 2010, 3: 785-798. 10.1242/dmm.005447.CrossRefPubMed Matigian N, Abrahamsen G, Sutharsan R, Cook AL, Vitale AM, Nouwens A, Bellette B, An J, Anderson M, Beckhouse AG, et al: Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech. 2010, 3: 785-798. 10.1242/dmm.005447.CrossRefPubMed
17.
go back to reference Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Schule B, Dolmetsch RE, Langston W, et al: LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011, 8: 267-280. 10.1016/j.stem.2011.01.013.PubMedCentralCrossRefPubMed Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Schule B, Dolmetsch RE, Langston W, et al: LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011, 8: 267-280. 10.1016/j.stem.2011.01.013.PubMedCentralCrossRefPubMed
18.
go back to reference Sies H: Glutathione and its role in cellular functions. Free Radic Biol Med. 1999, 27: 916-921. 10.1016/S0891-5849(99)00177-X.CrossRefPubMed Sies H: Glutathione and its role in cellular functions. Free Radic Biol Med. 1999, 27: 916-921. 10.1016/S0891-5849(99)00177-X.CrossRefPubMed
19.
go back to reference Williamson TP, Johnson DA, Johnson JA: Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. Neurotoxicology. 2012, 33: 272-279. 10.1016/j.neuro.2012.01.015.PubMedCentralCrossRefPubMed Williamson TP, Johnson DA, Johnson JA: Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. Neurotoxicology. 2012, 33: 272-279. 10.1016/j.neuro.2012.01.015.PubMedCentralCrossRefPubMed
20.
go back to reference Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL: Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol. 2007, 66: 75-85. 10.1097/nen.0b013e31802d6da9.PubMedCentralCrossRefPubMed Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL: Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol. 2007, 66: 75-85. 10.1097/nen.0b013e31802d6da9.PubMedCentralCrossRefPubMed
21.
go back to reference Tufekci KU, Civi Bayin E, Genc S, Genc K: The Nrf2/ARE Pathway: a promising target to counteract mitochondrial dysfunction in parkinson's disease. Parkinsons Dis. 2011, 2011: 314082-PubMedCentralPubMed Tufekci KU, Civi Bayin E, Genc S, Genc K: The Nrf2/ARE Pathway: a promising target to counteract mitochondrial dysfunction in parkinson's disease. Parkinsons Dis. 2011, 2011: 314082-PubMedCentralPubMed
22.
go back to reference Fukae J, Mizuno Y, Hattori N: Mitochondrial dysfunction in Parkinson's disease. Mitochondrion. 2007, 7: 58-62. 10.1016/j.mito.2006.12.002.CrossRefPubMed Fukae J, Mizuno Y, Hattori N: Mitochondrial dysfunction in Parkinson's disease. Mitochondrion. 2007, 7: 58-62. 10.1016/j.mito.2006.12.002.CrossRefPubMed
23.
go back to reference Schapira AH: Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta. 1998, 1366: 225-233. 10.1016/S0005-2728(98)00115-7.CrossRefPubMed Schapira AH: Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta. 1998, 1366: 225-233. 10.1016/S0005-2728(98)00115-7.CrossRefPubMed
24.
go back to reference Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003, 100: 4078-4083. 10.1073/pnas.0737556100.PubMedCentralCrossRefPubMed Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003, 100: 4078-4083. 10.1073/pnas.0737556100.PubMedCentralCrossRefPubMed
25.
go back to reference Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O: Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008, 64: 555-565. 10.1002/ana.21492.PubMedCentralCrossRefPubMed Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O: Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008, 64: 555-565. 10.1002/ana.21492.PubMedCentralCrossRefPubMed
26.
go back to reference Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, et al: PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 2010, 189: 211-221. 10.1083/jcb.200910140.PubMedCentralCrossRefPubMed Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, et al: PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 2010, 189: 211-221. 10.1083/jcb.200910140.PubMedCentralCrossRefPubMed
27.
go back to reference Narendra D, Tanaka A, Suen DF, Youle RJ: Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008, 183: 795-803. 10.1083/jcb.200809125.PubMedCentralCrossRefPubMed Narendra D, Tanaka A, Suen DF, Youle RJ: Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008, 183: 795-803. 10.1083/jcb.200809125.PubMedCentralCrossRefPubMed
28.
go back to reference Tanaka A: Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 2010, 584: 1386-1392. 10.1016/j.febslet.2010.02.060.PubMedCentralCrossRefPubMed Tanaka A: Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 2010, 584: 1386-1392. 10.1016/j.febslet.2010.02.060.PubMedCentralCrossRefPubMed
29.
go back to reference Yoshii SR, Kishi C, Ishihara N, Mizushima N: Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem. 2011, 286: 19630-19640. 10.1074/jbc.M110.209338.PubMedCentralCrossRefPubMed Yoshii SR, Kishi C, Ishihara N, Mizushima N: Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem. 2011, 286: 19630-19640. 10.1074/jbc.M110.209338.PubMedCentralCrossRefPubMed
30.
go back to reference Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D: Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci. 2011, 31: 5970-5976. 10.1523/JNEUROSCI.4441-10.2011.PubMedCentralCrossRefPubMed Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D: Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci. 2011, 31: 5970-5976. 10.1523/JNEUROSCI.4441-10.2011.PubMedCentralCrossRefPubMed
32.
go back to reference Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, et al: Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005, 58: 411-422. 10.1002/ana.20587.CrossRefPubMed Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, et al: Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005, 58: 411-422. 10.1002/ana.20587.CrossRefPubMed
33.
go back to reference Sasaki S, Shirata A, Yamane K, Iwata M: Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions. Neurology. 2004, 63: 678-682. 10.1212/01.WNL.0000134657.25904.0B.CrossRefPubMed Sasaki S, Shirata A, Yamane K, Iwata M: Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions. Neurology. 2004, 63: 678-682. 10.1212/01.WNL.0000134657.25904.0B.CrossRefPubMed
34.
go back to reference Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, et al: Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol. 2002, 160: 1655-1667. 10.1016/S0002-9440(10)61113-3.PubMedCentralCrossRefPubMed Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, et al: Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol. 2002, 160: 1655-1667. 10.1016/S0002-9440(10)61113-3.PubMedCentralCrossRefPubMed
35.
go back to reference Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM: Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med. 2001, 7: 1144-1150. 10.1038/nm1001-1144.CrossRefPubMed Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM: Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med. 2001, 7: 1144-1150. 10.1038/nm1001-1144.CrossRefPubMed
36.
go back to reference Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR: Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron. 2002, 36: 1007-1019. 10.1016/S0896-6273(02)01125-X.CrossRefPubMed Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR: Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron. 2002, 36: 1007-1019. 10.1016/S0896-6273(02)01125-X.CrossRefPubMed
37.
go back to reference Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ: Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (New York, NY). 2001, 293: 263-269. 10.1126/science.1060627.CrossRef Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ: Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (New York, NY). 2001, 293: 263-269. 10.1126/science.1060627.CrossRef
38.
go back to reference Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, Nabetani A, Ishikawa F, Arai Y, Hirose N, et al: Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One. 2012, 7: e41572-10.1371/journal.pone.0041572.PubMedCentralCrossRefPubMed Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, Nabetani A, Ishikawa F, Arai Y, Hirose N, et al: Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One. 2012, 7: e41572-10.1371/journal.pone.0041572.PubMedCentralCrossRefPubMed
39.
go back to reference Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, et al: Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA. 2010, 107: 15921-15926. 10.1073/pnas.1010209107.PubMedCentralCrossRefPubMed Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, Yow A, Soldner F, Hockemeyer D, Hallett PJ, et al: Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA. 2010, 107: 15921-15926. 10.1073/pnas.1010209107.PubMedCentralCrossRefPubMed
40.
go back to reference Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease-Specific Induced Pluripotent Stem Cells. Cell. 2008 Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease-Specific Induced Pluripotent Stem Cells. Cell. 2008
41.
go back to reference Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, et al: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009, 136: 964-977. 10.1016/j.cell.2009.02.013.PubMedCentralCrossRefPubMed Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, et al: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009, 136: 964-977. 10.1016/j.cell.2009.02.013.PubMedCentralCrossRefPubMed
42.
go back to reference Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman JW, et al: Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun. 2011, 2: 440-PubMedCentralCrossRefPubMed Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman JW, et al: Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun. 2011, 2: 440-PubMedCentralCrossRefPubMed
43.
go back to reference Suemori H, Yasuchika K, Hasegawa K, Fujioka T, Tsuneyoshi N, Nakatsuji N: Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun. 2006, 345: 926-932. 10.1016/j.bbrc.2006.04.135.CrossRefPubMed Suemori H, Yasuchika K, Hasegawa K, Fujioka T, Tsuneyoshi N, Nakatsuji N: Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun. 2006, 345: 926-932. 10.1016/j.bbrc.2006.04.135.CrossRefPubMed
44.
go back to reference Okada Y, Matsumoto A, Shimazaki T, Enoki R, Koizumi A, Ishii S, Itoyama Y, Sobue G, Okano H: Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem cells (Dayton, Ohio). 2008, 26: 3086-3098. 10.1634/stemcells.2008-0293.CrossRef Okada Y, Matsumoto A, Shimazaki T, Enoki R, Koizumi A, Ishii S, Itoyama Y, Sobue G, Okano H: Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem cells (Dayton, Ohio). 2008, 26: 3086-3098. 10.1634/stemcells.2008-0293.CrossRef
45.
go back to reference Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, et al: Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol. 2005, 167: 1713-1728. 10.1016/S0002-9440(10)61253-9.PubMedCentralCrossRefPubMed Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, et al: Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol. 2005, 167: 1713-1728. 10.1016/S0002-9440(10)61253-9.PubMedCentralCrossRefPubMed
46.
go back to reference Mitsui J, Takahashi Y, Goto J, Tomiyama H, Ishikawa S, Yoshino H, Minami N, Smith DI, Lesage S, Aburatani H, et al: Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet. 2010, 87: 75-89. 10.1016/j.ajhg.2010.06.006.PubMedCentralCrossRefPubMed Mitsui J, Takahashi Y, Goto J, Tomiyama H, Ishikawa S, Yoshino H, Minami N, Smith DI, Lesage S, Aburatani H, et al: Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet. 2010, 87: 75-89. 10.1016/j.ajhg.2010.06.006.PubMedCentralCrossRefPubMed
Metadata
Title
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
Authors
Yoichi Imaizumi
Yohei Okada
Wado Akamatsu
Masato Koike
Naoko Kuzumaki
Hideki Hayakawa
Tomoko Nihira
Tetsuro Kobayashi
Manabu Ohyama
Shigeto Sato
Masashi Takanashi
Manabu Funayama
Akiyoshi Hirayama
Tomoyoshi Soga
Takako Hishiki
Makoto Suematsu
Takuya Yagi
Daisuke Ito
Arifumi Kosakai
Kozo Hayashi
Masanobu Shouji
Atsushi Nakanishi
Norihiro Suzuki
Yoshikuni Mizuno
Noboru Mizushima
Masayuki Amagai
Yasuo Uchiyama
Hideki Mochizuki
Nobutaka Hattori
Hideyuki Okano
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Molecular Brain / Issue 1/2012
Electronic ISSN: 1756-6606
DOI
https://doi.org/10.1186/1756-6606-5-35

Other articles of this Issue 1/2012

Molecular Brain 1/2012 Go to the issue